Skip to main content
. 2023 Oct 9;14:1221097. doi: 10.3389/fimmu.2023.1221097

Table 1.

Comparison of differentially expressed and regulated genes, molecules, signatures, and cell in primary tumor versus brain metastases.

Increased
abundance or expression in primary tumor
Increased
abundance or expression in BM
Decreased abundance or expression in BM
CD4+ T cells Mutations in STK11, FAM129C, ADAMTS, and APOBEC signature Th1 and CD8 T genes
CD8+ T cells TMB Expression of VCAM1
CD+ FOXP3 Higher number of somatic mutations Leukocyte extravasation signaling
PD-L1 expression* Higher variant allelic frequency of mutated genes. Th1 immune response
Invasion, metastasis, and metabolic-associated pathways Reduced T cell heterogeneity
Alterations in Hippo pathway Dendritic cell maturation
PD-L1 expression* CD8+ T cells
Macrophages (not TAMs)
CTLA-4

*Discordant results.